PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-66.07%
G&A reduction while CRON.TO shows 4.56% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-66.07%
Operating expenses reduction while CRON.TO shows 11.36% growth. Joel Greenblatt would examine advantage.
-66.07%
Total costs reduction while CRON.TO shows 6.73% growth. Joel Greenblatt would examine advantage.
30.56%
Interest expense change of 30.56% while CRON.TO maintains costs. Bruce Berkowitz would investigate control.
No Data
No Data available this quarter, please select a different quarter.
66.07%
EBITDA growth 1.25-1.5x CRON.TO's 47.71%. Bruce Berkowitz would examine sustainability.
No Data
No Data available this quarter, please select a different quarter.
66.07%
Operating income growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
30.56%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
71.07%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
71.07%
Net income growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
71.05%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
71.05%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
-0.38%
Share count reduction while CRON.TO shows 25.88% change. Joel Greenblatt would examine strategy.
-0.38%
Diluted share reduction while CRON.TO shows 25.88% change. Joel Greenblatt would examine strategy.